遮盖疗法在白癜风治疗中的应用

doi:10.3760/cma.j.issn.0412-4030.2019.04.014

Abstract

Abstract: 【Abstract】 At present, specific targeted treatment of vitiligo is still lacking, and there are many limitations of current therapies, such as slow repigmentation process, long duration of treatment and frequent recurrence. As a therapeutic strategy for rapidly improving the appearance of patients, camouflage therapy has a unique advantage in the treatment of various skin diseases. Several studies in China and other countries have shown that the correct use of cosmetic camouflage can effectively improve the appearance and quality of life of patients with vitiligo. This review summarizes the knowledge about various camouflage therapies and related clinical researches on the relationship between camouflage therapies and quality of life of patients with vitiligo, and elaborates application prospects of camouflage therapies in the treatment of vitiligo.

Key words: Vitiligo, Quality of life, Camouflage agents, Camouflage therapy

Zhang Shaolong, Chang Yuqian, Lin Xingxiao, Su Xin, Jian Zhe, Li Chunying. Application of camouflage therapy in vitiligo[J].Chinese Journal of Dermatology, 2019, 52(4): 283-285.

References ［26］

［1］	Ezzedine K, Eleftheriadou V, Whitton M, et al. Vitiligo［J］. Lancet, 2015,386（9988）:74⁃84. doi: 10.1016/S0140⁃6736（14）60763⁃7.
［2］	LeRoy L. Camouflage therapy［J］. Dermatol Nurs, 2000,12（6）:415⁃416, 442.
［3］	Kornhaber R, Visentin D, Thapa DK, et al. Cosmetic camouflage improves quality of life among patients with skin disfigurement: a systematic review［J］. Body Image, 2018,27:98⁃108. doi: 10.1016/j.bodyim.2018.08.004.
［4］	Davey L, Clarke V, Jenkinson E. Living with alopecia areata: an online qualitative survey study［J］. Br J Dermatol, 2018. doi: 10.1111/bjd.17463.
［5］	Saed S, Ibrahim O, Bergfeld WF. Hair camouflage: a compre⁃hensive review［J］. Int J Womens Dermatol, 2017,3（1 Suppl）:S75⁃S80. doi: 10.1016/j.ijwd.2017.02.016.
［6］	Rassman WR, Pak JP, Kim J, et al. Scalp micropigmentation: a concealer for hair and scalp deformities［J］. J Clin Aesthet Dermatol, 2015,8（3）:35⁃42.
［7］	Maskell J, Newcombe P, Martin G, et al. Psychological and psychosocial functioning of children with burn scarring using cosmetic camouflage: a multi⁃centre prospective randomised controlled trial［J］. Burns, 2014,40（1）:135⁃149. doi: 10.1016/j.burns.2013.04.025.
［8］	Kaliyadan F, Kumar A. Camouflage for patients with vitiligo［J］. Indian J Dermatol Venereol Leprol, 2012,78（1）:8⁃15.
［9］	De Cuyper C. Permanent makeup: indications and complications［J］. Clin Dermatol, 2008,26（1）:30⁃34. doi: 10.1016/j.clindermatol. 2007.10.009.
［10］	Garg G, Thami GP. Micropigmentation: tattooing for medical purposes［J］. Dermatol Surg, 2005,31（8 Pt 1）:928⁃931; discussion 931.
［11］	Halder RM, Pham HN, Breadon JY, et al. Micropigmentation for the treatment of vitiligo［J］. J Dermatol Surg Oncol, 1989,15（10）:1092⁃1098.
［12］	Singh AK, Karki D. Micropigmentation: tattooing for the treatment of lip vitiligo［J］. J Plast Reconstr Aesthet Surg, 2010,63（6）:988⁃991. doi: 10.1016/j.bjps.2009.03.013.
［13］	Hossain C, Porto DA, Hamzavi I, et al. Camouflaging agents for vitiligo patients［J］. J Drugs Dermatol, 2016,15（4）:384⁃387.
［14］	Levy LL, Emer JJ. Emotional benefit of cosmetic camouflage in the treatment of facial skin conditions: personal experience and review［J］. Clin Cosmet Investig Dermatol, 2012,5:173⁃182. doi: 10.2147/CCID.S33860.
［15］	Shin S, Shin JY, Lee H, et al. Spreading of pre⁃existing segmental vitiligo after immunotherapy with house dust mite in a patient with atopic dermatitis［J］. Clin Exp Dermatol, 2015,40（8）:920⁃921. doi: 10.1111/ced.12443.
［16］	Kang P, Zhang W, Chen X, et al. TRPM2 mediates mitochondria⁃dependent apoptosis of melanocytes under oxidative stress［J］. Free Radic Biol Med, 2018,126:259⁃268. doi: 10.1016/j.freerad biomed.2018.08.022.
［17］	Salsberg JM, Weinstein M, Shear N, et al. Impact of cosmetic camouflage on the quality of life of children with skin disease and their families［J］. J Cutan Med Surg, 2016,20（3）:211⁃215. doi: 10.1177/1203475415595175.
［18］	Dahir AM, Thomsen SF. Comorbidities in vitiligo: comprehensive review［J］. Int J Dermatol, 2018,57（10）:1157⁃1164. doi: 10. 1111/ijd.14055.
［19］	Ezzedine K, Sheth V, Rodrigues M, et al. Vitiligo is not a cosmetic disease［J］. J Am Acad Dermatol, 2015,73（5）:883⁃885. doi: 10.1016/j.jaad.2015.07.039.
［20］	Morrison B, Burden⁃Teh E, Batchelor JM, et al. Quality of life in people with vitiligo: a systematic review and meta⁃analysis［J］. Br J Dermatol, 2017,177（6）:e338⁃e339. doi: 10.1111/bjd. 15933.
［21］	Tanioka M, Yamamoto Y, Kato M, et al. Camouflage for patients with vitiligo vulgaris improved their quality of life［J］. J Cosmet Dermatol, 2010,9（1）:72⁃75. doi: 10.1111/j.1473⁃2165.2010. 00479.x.
［22］	Ramien ML, Ondrejchak S, Gendron R, et al. Quality of life in pediatric patients before and after cosmetic camouflage of visible skin conditions［J］. J Am Acad Dermatol, 2014,71（5）:935⁃940. doi: 10.1016/j.jaad.2014.07.029.
［23］	Ongenae K, Dierckxsens L, Brochez L, et al. Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage［J］. Dermatology, 2005,210（4）:279⁃285. doi: 10.1159/000084751.
［24］	胡蔚毅, 王学民, 吴佩兰, 等. 白斑遮盖型粉底液对改善寻常型白癜风患者生活质量有效性研究［J］. 临床皮肤科杂志, 2011,40（8）:484⁃485. doi: 10.3969/j.issn.1000⁃4963.2011.08.016.
［25］	Xijing Hospital. Effects of camouflage on the life quality of patients with vitiligo［DB/OL］. （2018⁃05⁃30）［2019⁃01⁃01］. https://clinicaltrials.gov/ct2/show/NCT03540966.
［26］	中国中西医结合学会皮肤性病专业委员会色素病学组. 白癜风诊疗共识（2018版）［J］. 中华皮肤科杂志, 2018,51（4）:247⁃250. doi: 10.3760/cma.j.issn.0412⁃4030.2018.04.001.

[1]	Jin Rong, Hong Weisong, Xu Ai’e. Autologous cultured melanocyte transplantation for the treatment of genital vitiligo [J]. Chinese Journal of Dermatology, 2019, 52(6): 429-430.
[2]	Shi Jiaqi, Li Xue, Sun Li, Zhao Wen′e, Ding Shuhong, Hou Xiaoyuan, Xiu Yanyan, Lu Yan. In vitro effect of low-concentration hydrogen peroxide on autophagy in human melanocytes and screening for autophagy-related lncRNAs [J]. Chinese Journal of Dermatology, 2019, 52(6): 383-388.
[3]	Chen Xuguang, Ma Jinyuan, Zhang Yuwei, Guo Yanyang, Liu Ling, Li Chunying. Application of dermoscopy in the diagnosis and differential diagnosis of vitiligo [J]. Chinese Journal of Dermatology, 2019, 52(6): 425-428.
[4]	Hou Xiaoyuan, Lu Yan. Application of platelet-rich plasma in dermatology [J]. Chinese Journal of Dermatology, 2019, 52(4): 279-282.
[5]	Xiao Yi, Chen Liping, Jing Danrong, Su Juan, Li Meng, Shen Minxue, Chen Xiang. Application and significance of willingness-to-pay in measuring the burden of skin diseases [J]. Chinese Journal of Dermatology, 2019, 52(4): 286-289.
[6]	Lei Jiehao, Fan Qimin, Chen Rong, Xu Ai′e. Association between efficacy of and response to narrow-band ultraviolet B phototherapy as well as factors related to phototherapy response in patients with vitiligo [J]. Chinese Journal of Dermatology, 2019, 52(4): 259-262.
[7]	Working Committee on Standardized Diagnosis and Treatment, China Dermatologist Association, Dermatological Surgical Equipment Group and Skin Phototherapy Group, Committee on Skin Disease and Cosmetic Dermatology, China Association of Medical Equipment. Clinical application of home narrow band ultraviolet B phototherapy: an expert consensus statement [J]. Chinese Journal of Dermatology, 2019, 52(3): 156-161.
[8]	Yuan Guo Yu-Tian Cai Ning-Ning Guo. Expression of nucleobindin 2-encoded satiety and fat-influencing protein-1 and interleukin-26 in the serum of patients with vitiligo and its significance [J]. Chinese Journal of Dermatology, 2019, 52(2): 94-99.
[9]	Wang-Min Qing-wei Geng Ya-li Gao You Song XiuZu. Effect of narrow-band ultraviolet B radiation on the autophagy of cultured human melanocytes in vitro [J]. Chinese Journal of Dermatology, 2018, 51(9): 665-669.
[10]	Ming LI jianmin chang. Clinical scoring systems of vitiligo [J]. Chinese Journal of Dermatology, 2018, 51(6): 478-479.
[11]	. Efficacy of 308-nm excimer laser versus high-intensity ultraviolet radiation for the treatment of active localized vitiligo [J]. Chinese Journal of Dermatology, 2018, 51(6): 413-416.
[12]	. Effects of tacrolimus on the secretion of chemokines CXCL9 and CXCL10 by γ-interferon-simulated HaCaT cells [J]. Chinese Journal of Dermatology, 2018, 51(5): 375-378.
[13]	Jin Rong, Zhu Yiping, Lin Fuquan, Liu Dongyin, Fu Lifang, Xu Ai′e. Protective effect of WSY6, a caffeic acid derivative, on oxidative stress injury in melanocytes and its mechanism [J]. Chinese Journal of Dermatology, 2018, 51(12): 869-873.
[14]	Lu Wenjing, Zhao Yu, Wang Keyu. Geniposide protects melanocytes from oxidative damage through the PI3K-Akt pathway [J]. Chinese Journal of Dermatology, 2018, 51(11): 797-801.
[15]	Qian Yuetong, Liu Jiawei, Liu Wei, Ma Donglai. Autoimmune polyglandular syndrome type Ⅳ: thymoma, vitiligo, myasthenia gravis, systemic lupus erythematosus, pemphigus vulgaris and alopecia universalis successively occurred in a patient [J]. Chinese Journal of Dermatology, 2018, 51(10): 733-736.

Application of camouflage therapy in vitiligo

PDF

Like

Knowledge

Abstract

Cite this article

share this article

References ［26］

Related Articles 15

Metrics

Comments

Recommended 10